Common Bone Drug may Increase Life of Replacement Joints

People who take bisphosphonates, a common bone drug after joint replacement surgery are less likely to need a repeat operation, finds a new study published on bmj.com today.

People who take bisphosphonates, a common bone drug, after joint replacement surgery are less likely to need a repeat operation, finds a new study published on bmj.com today.

While hip and knee replacements are cost effective procedures, substantial numbers of patients require revision surgery within 10 years to replace the implant because of infection, wear, loosening, or other mechanical failures.

Knee Replacement
Make sprinting a possibility! Relieve chronic arthritic pain by having a knee replacement done at affordable prices. Check out our list of world-class hospitals.

Oral bisphosphonates are used to prevent fractures and to treat common bone diseases like osteoporosis. Some experts think that bisphosphonates may improve the survival time of replacement joints through their effects on reducing bone resorption, but evidence is scarce and controversial.

So a team of researchers, led by Professor Nigel Arden at the University of Oxford, set out to test whether bisphosphonate use is related to improved implant survival time.

Using data from the General Practice Research Database, which contains anonymised data on three million UK primary care patients, they identified all patients over the age of 40 undergoing hip or knee replacement surgery from 1986-2006 for osteoarthritis.

Hip Replacement-Osteoarthritis-Post Operative Complications
Are you experiencing pain due to damaged hips? Travel abroad to get replacement surgery at affordable prices.

Patients who were prescribed bisphosphonates at least six months before revision surgery were defined as bisphosphonate users. Non-users were defined as those who were never prescribed bisphosphonates or who had their first prescription after revision surgery.

Factors that could affect the results, such as age, sex, body mass index (BMI), smoking status, alcohol intake, use of calcium and vitamin D supplements, and previous fractures were also taken into account.

Osteoarthritis - Causes, Symptoms, DIagnosis, Treatment, FAQs
Osteoarthritis is one of the commonest joint disorder and occurs as we age due to wear and tear of a joint. Osteoarthritis can affect any joint of the body.

Patients were tracked for a maximum of 15 years after their operation to calculate the rate of revision surgery.

Bisphosphonate users had a lower rate of revision rate at five years than non-users. Bisphosphonate use was associated with an almost twofold increase in implant survival time.

Diet, Nutrition and Supplements for Osteo-Arthritis and Rheumatoid Arthritis
Rheumatoid arthritis patients should consume a diet rich in natural antioxidant and anti-inflammatory nutrients and avoid foods like sugar, saturated fats, and trans fatty acids.

The researchers estimate that, for every 107 joint replacement patients taking bisphosphonates, one revision operation would be avoided.

And they suggest that the results could be due to bisphosphonate therapy suppressing the long term inflammatory response around the implant after surgery that often leads to bone loss and loosening of the implant.

Further studies are needed to confirm these findings, write the authors. However, they say that the protective effect of bisphosphonates seen in this study can be assumed to be valid for the wider population of patients undergoing total hip or knee replacement in the UK.

Source-Eurekalert